InsiderTrades.com logo

SRPT Insider Trading

Insider Ownership Percentage: 7.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $417,409.75

Sarepta Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Sarepta Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sarepta Therapeutics Share Price & Price History

Current Price: $17.13
Price Change: ▲ Price Increase of +0.481 (2.89%)
As of 03/20/2026 12:38 PM ET

This chart shows the closing price history over time for SRPT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Sarepta Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/12/2026Stephen MayoDirectorSell7,239$17.02$123,207.781,765View SEC Filing Icon  
12/16/2025Ian Michael EstepanCOOSell13,187$22.31$294,201.97193,300View SEC Filing Icon  
3/12/2025Claude NicaiseDirectorSell2,491$99.64$248,203.2427,812View SEC Filing Icon  
12/12/2024Hans Rudolf WigzellDirectorSell10,500$124.84$1,310,820.0022,840View SEC Filing Icon  
12/5/2024Kathryn Jean BoorDirectorSell1,636$125.55$205,399.805,880View SEC Filing Icon  
8/30/2024Ian Michael EstepanCFOSell5,985$137.36$822,099.6033,946View SEC Filing Icon  
8/16/2024Michael Andrew ChambersDirectorBuy37,038$133.80$4,955,684.40284,034View SEC Filing Icon  
6/25/2024Ryan Edward BrownEVPSell38,957$161.61$6,295,840.7717,129View SEC Filing Icon  
6/24/2024Bilal ArifInsiderSell7,859$163.08$1,281,645.7221,261View SEC Filing Icon  
5/2/2024Dallan MurrayInsiderSell3,635$140.00$508,900.0018,125View SEC Filing Icon  
3/11/2024Kathryn Jean BoorDirectorSell761$122.93$93,549.737,516View SEC Filing Icon  
3/8/2024Hans Rudolf WigzellDirectorSell15,000$123.25$1,848,750.0022,840View SEC Filing Icon  
3/5/2024Stephen MayoDirectorSell3,135$122.96$385,479.606,621View SEC Filing Icon  
3/1/2024Bilal ArifInsiderSell2,000$128.84$257,680.0026,836View SEC Filing Icon  
3/1/2024Ian Michael EstepanCFOSell1,200$128.30$153,960.0039,114View SEC Filing Icon  
11/3/2023Douglas S. IngramCEOBuy25,225$79.36$2,001,856.00390,307View SEC Filing Icon  
11/3/2023Richard BarryDirectorBuy50,000$78.81$3,940,500.00140,000View SEC Filing Icon  
8/14/2023Michael Andrew ChambersDirectorBuy9,979$109.47$1,092,401.13246,996View SEC Filing Icon  
8/10/2023Michael Andrew ChambersDirectorBuy34,867$106.15$3,701,132.05213,331View SEC Filing Icon  
8/4/2023Hans Rudolf WigzellDirectorSell15,000$106.72$1,600,800.0020,994View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Sarepta Therapeutics (NASDAQ:SRPT)

86.68% of Sarepta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SRPT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Sarepta Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/17/2026Rockefeller Capital Management L.P.4,104$88K0.0%+98.3%0.004%Search for SEC Filing on Google Icon
2/19/2026T. Rowe Price Investment Management Inc.892,065$19.20M0.0%-34.7%0.851%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.397,001$8.54M0.0%-52.3%0.379%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC10,492$0.23M0.0%-14.7%0.010%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV95,752$2.06M0.0%+340.7%0.091%Search for SEC Filing on Google Icon
2/18/2026Vident Advisory LLC12,555$0.27M0.0%-39.8%0.012%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury39,905$0.81M0.0%-6.0%0.038%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC9,883$0.21M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp58,042$1.25M0.0%+17.1%0.055%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC878,393$18.90M0.1%-32.9%0.838%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC31,741$0.68M0.2%+166.5%0.030%Search for SEC Filing on Google Icon
2/18/2026Tang Capital Management LLC349,220$7.52M0.4%-41.8%0.333%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC1,000,109$21.52M0.0%+251.9%0.954%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC221,730$4.77M0.0%N/A0.212%Search for SEC Filing on Google Icon
2/18/2026Evolve Private Wealth LLC12,026$0.26M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/18/2026683 Capital Management LLC810,000$17.43M0.8%-18.2%0.773%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC51,942$1.12M0.0%-8.5%0.050%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC28,866$0.62M0.0%-91.7%0.028%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC24,620$0.53M0.0%+3.8%0.023%Search for SEC Filing on Google Icon
2/17/2026PDT Partners LLC105,486$2.27M0.1%-9.3%0.101%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC7,796,535$167.78M0.1%+454.6%7.440%Search for SEC Filing on Google Icon
2/17/2026MPM Bioimpact LLC70,000$1.51M0.2%-90.0%0.067%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP178,343$3.84M0.0%+11.0%0.170%Search for SEC Filing on Google Icon
2/17/2026Amundi10,257$0.22M0.0%-98.9%0.010%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC168,897$3.64M0.0%-43.9%0.161%Search for SEC Filing on Google Icon
2/17/2026T. Rowe Price Investment Management Inc.369,831$7.96M0.0%-72.9%0.353%Search for SEC Filing on Google Icon
2/17/2026Quantitative Investment Management LLC63,670$1.37M0.1%N/A0.061%Search for SEC Filing on Google Icon
2/17/2026Public Employees Retirement System of Ohio27,912$0.60M0.0%-3.7%0.027%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System94,545$2.04M0.0%+15.1%0.090%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.299,415$6.44M0.0%+77.9%0.286%Search for SEC Filing on Google Icon
2/17/2026Maryland State Retirement & Pension System19,543$0.42M0.0%+6.9%0.019%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors48,752$1.05M0.0%+268.4%0.047%Search for SEC Filing on Google Icon
2/17/2026&PARTNERS112,446$2.23M0.0%N/A0.107%Search for SEC Filing on Google Icon
2/17/2026Blair William & Co. IL26,333$0.57M0.0%-21.7%0.025%Search for SEC Filing on Google Icon
2/16/2026OMERS ADMINISTRATION Corp41,254$0.89M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC257,089$5.53M0.0%+373.5%0.245%Search for SEC Filing on Google Icon
2/16/2026Healthcare of Ontario Pension Plan Trust Fund479,246$10.31M0.0%N/A0.457%Search for SEC Filing on Google Icon
2/16/2026Landscape Capital Management L.L.C.79,671$1.72M0.1%N/A0.076%Search for SEC Filing on Google Icon
2/16/2026Clear Street Group Inc.432,996$9.32M0.0%N/A0.413%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP35,681$0.77M0.0%-22.7%0.034%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC1,165$25K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP143,493$3.09M0.0%+36.5%0.137%Search for SEC Filing on Google Icon
2/13/2026Quinn Opportunity Partners LLC19,843$0.43M0.0%-94.7%0.019%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co89,219$1.92M0.0%-8.1%0.085%Search for SEC Filing on Google Icon
2/13/2026Bridgewater Associates LP280,568$6.04M0.0%-20.4%0.268%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp51,108$1.10M0.0%N/A0.049%Search for SEC Filing on Google Icon
2/13/2026Commerce Bank24,333$0.52M0.0%+6.2%0.023%Search for SEC Filing on Google Icon
2/13/2026Bridgefront Capital LLC9,866$0.21M0.1%N/A0.009%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group235,021$5.05M0.0%N/A0.224%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.553,379$11.91M0.0%+110.9%0.528%Search for SEC Filing on Google Icon
2/13/2026Public Sector Pension Investment Board362,667$7.81M0.0%-4.9%0.346%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC195,257$4.20M0.0%+11.5%0.186%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP1,992,577$42.88M0.0%+2.7%1.901%Search for SEC Filing on Google Icon
2/13/2026Integrated Wealth Concepts LLC15,587$0.34M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.765,383$16.47M0.0%+25.6%0.730%Search for SEC Filing on Google Icon
2/13/2026Van ECK Associates Corp12,284$0.26M0.0%+23.6%0.012%Search for SEC Filing on Google Icon
2/13/2026State Street Corp6,599,441$142.02M0.0%-54.6%6.298%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC475,004$10.22M0.0%+597.8%0.453%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC266,549$5.74M0.0%+14.2%0.254%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN167,725$3.61M0.0%-49.0%0.160%Search for SEC Filing on Google Icon
2/12/2026Advisors Asset Management Inc.10,995$0.24M0.0%-9.6%0.010%Search for SEC Filing on Google Icon
2/12/2026State Board of Administration of Florida Retirement System78,337$1.69M0.0%-6.3%0.075%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC1,159,578$24.95M0.0%-56.2%1.107%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP458,148$9.86M0.0%-29.7%0.437%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.1,313,313$28.26M0.0%+0.4%1.253%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc6,243$0.13M0.0%-60.7%0.006%Search for SEC Filing on Google Icon
2/12/2026Bank of Montreal Can15,130$0.33M0.0%+29.9%0.014%Search for SEC Filing on Google Icon
2/12/2026Alps Advisors Inc.86,037$1.85M0.0%N/A0.082%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank195,983$4.22M0.0%+14.3%0.187%Search for SEC Filing on Google Icon
2/12/2026Caerus Investment Advisors LLC18,222$0.39M0.1%N/A0.017%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC196,719$4.23M0.0%+14.6%0.188%Search for SEC Filing on Google Icon
2/11/2026Inceptionr LLC16,091$0.35M0.1%N/A0.015%Search for SEC Filing on Google Icon
2/11/2026Janney Montgomery Scott LLC9,759$0.21M0.0%-77.3%0.009%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG11,990$0.26M0.0%+25.1%0.011%Search for SEC Filing on Google Icon
2/11/2026Focus Partners Advisor Solutions LLC28,471$0.61M0.0%+56.7%0.027%Search for SEC Filing on Google Icon
2/11/2026Cerity Partners LLC212,316$4.57M0.0%+456.8%0.203%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC49,777$1.07M0.0%-44.7%0.048%Search for SEC Filing on Google Icon
2/11/2026Erste Asset Management GmbH2,728,945$58.73M0.5%+1.6%2.604%Search for SEC Filing on Google Icon
2/11/2026ING Groep NV87,362$1.88M0.0%-63.7%0.083%Search for SEC Filing on Google Icon
2/11/2026WINTON GROUP Ltd11,300$0.24M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming6,988$0.15M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/10/2026Sivia Capital Partners LLC13,114$0.28M0.1%N/A0.013%Search for SEC Filing on Google Icon
2/10/2026Westpac Banking Corp7,173$0.15M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/10/2026Dynasty Wealth Management LLC12,283$0.26M0.0%-14.3%0.012%Search for SEC Filing on Google Icon
2/10/2026AXQ Capital LP20,247$0.44M0.1%+38.5%0.019%Search for SEC Filing on Google Icon
2/10/2026Commonwealth of Pennsylvania Public School Empls Retrmt SYS25,942$0.56M0.0%+4.2%0.025%Search for SEC Filing on Google Icon
2/10/2026BNP Paribas Financial Markets727,786$15.66M0.0%-59.1%0.695%Search for SEC Filing on Google Icon
2/10/2026Norges Bank370,701$7.98M0.0%N/A0.354%Search for SEC Filing on Google Icon
2/10/2026Baker Avenue Asset Management LP57,238$1.23M0.0%-7.8%0.055%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC1,904,325$40.99M0.0%+10.6%1.817%Search for SEC Filing on Google Icon
2/9/2026Clearstead Advisors LLC6,185$0.13M0.0%-50.0%0.006%Search for SEC Filing on Google Icon
2/9/2026Legal & General Group Plc264,457$5.69M0.0%-0.8%0.252%Search for SEC Filing on Google Icon
2/9/2026Hantz Financial Services Inc.2,784$60K0.0%+348.3%0.003%Search for SEC Filing on Google Icon
2/9/2026Catalyst Funds Management Pty Ltd9,500$0.20M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/6/2026EverSource Wealth Advisors LLC5,922$0.13M0.0%+435.9%0.006%Search for SEC Filing on Google Icon
2/6/2026Leonteq Securities AG3,526$76K0.0%N/A0.003%Search for SEC Filing on Google Icon
2/6/2026IFP Advisors Inc1,779$38K0.0%-62.5%0.002%Search for SEC Filing on Google Icon
2/6/2026PNC Financial Services Group Inc.8,115$0.18M0.0%+14.7%0.008%Search for SEC Filing on Google Icon
2/6/2026GSA Capital Partners LLP70,371$1.51M0.1%+242.2%0.067%Search for SEC Filing on Google Icon
2/6/2026Larson Financial Group LLC1,882$41K0.0%+82.5%0.002%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Sarepta Therapeutics logo
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Read More on Sarepta Therapeutics

Today's Range

Now: $17.13
Low: $16.66
High: $17.33

50 Day Range

MA: $18.97
Low: $15.87
High: $23.83

52 Week Range

Now: $17.13
Low: $10.41
High: $76.67

Volume

684,351 shs

Average Volume

2,641,589 shs

Market Capitalization

$1.80 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

Who are the company insiders with the largest holdings of Sarepta Therapeutics?

Sarepta Therapeutics' top insider investors include:
  1. Michael Andrew Chambers (Director)
  2. Ian Michael Estepan (COO)
  3. Ian Michael Estepan (CFO)
  4. Claude Nicaise (Director)
  5. Hans Lennart Rudolf Wigzell (Director)
  6. Bilal Arif (Insider)
  7. Dallan Murray (Insider)
  8. Ryan Edward Brown (EVP)
  9. Kathryn Jean Boor (Director)
  10. Stephen Mayo (Director)
Learn More about top insider investors at Sarepta Therapeutics.

Who are the major institutional investors of Sarepta Therapeutics?

Sarepta Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 11.27%
  2. AQR Capital Management LLC — 7.44%
  3. State Street Corp — 6.30%
  4. Erste Asset Management GmbH — 2.60%
  5. Aberdeen Group plc — 2.15%
  6. First Trust Advisors LP — 1.90%
Learn More about top institutional investors of Sarepta Therapeutics stock.

Which institutional investors are selling Sarepta Therapeutics stock?

During the previous quarter, SRPT stock was sold by these institutional investors:
  1. State Street Corp
  2. Renaissance Technologies LLC
  3. BNP Paribas Financial Markets
  4. T. Rowe Price Investment Management Inc.
  5. Amundi
  6. MPM Bioimpact LLC
  7. T. Rowe Price Investment Management Inc.
  8. Invesco Ltd.
During the previous year, company insiders that have sold Sarepta Therapeutics company stock include:
  1. Michael Andrew Chambers (Director)
  2. Ian Michael Estepan (COO)
Learn More investors selling Sarepta Therapeutics stock.

Which institutional investors are buying Sarepta Therapeutics stock?

During the previous quarter, SRPT stock was bought by institutional investors including:
  1. AQR Capital Management LLC
  2. Vanguard Group Inc.
  3. Millennium Management LLC
  4. Healthcare of Ontario Pension Plan Trust Fund
  5. Clear Street Group Inc.
  6. Ieq Capital LLC
  7. Norges Bank
  8. Jacobs Levy Equity Management Inc.